|
Insider Trading: Innophos Holdings, Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Innophos Holdings, Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Innophos Holdings, Inc. since year 2005. Table 2 shows the detailed insider transactions of Innophos Holdings, Inc. since 2005.
The reporting company's ticker symbol is IPHS.
The reporting company's CIK number is 1364099.
The total value of stock buying since 2005 is $710,062.
The total value of stock sales is $381,358,275.
The total value of stock exercises is $1,599,639.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Innophos Holdings, Inc. (IPHS) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Figure 2. Average prices of insider buys, sales, and option exercises at Innophos Holdings, Inc. (IPHS) in the past 24 months. See table 2 for insider transaction details.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Innophos Holdings, Inc. (IPHS).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 15,000 | 527,662 | 139,205 | 5,183,629 | 23,934 | 61,031 |
| 2008-07 | 0 | 0 | 33,600 | 964,576 | 111,020 | 283,100 |
| 2008-06 | 0 | 0 | 11,739,038 | 306,860,145 | 0 | 0 |
| 2008-05 | 0 | 0 | 5,000 | 89,023 | 0 | 0 |
| 2008-04 | 0 | 0 | 49,194 | 815,836 | 6,800 | 17,340 |
| 2008-03 | 0 | 0 | 96,254 | 1,451,960 | 0 | 0 |
| 2008-02 | 0 | 0 | 5,000 | 70,724 | 0 | 0 |
| 2008-01 | 0 | 0 | 33,600 | 478,684 | 12,100 | 30,854 |
| 2007-12 | 0 | 0 | 30,000 | 435,677 | 0 | 0 |
| 2007-11 | 0 | 0 | 10,000 | 129,975 | 0 | 0 |
| 2007-10 | 0 | 0 | 34,572 | 522,057 | 21,472 | 54,753 |
| 2007-07 | 0 | 0 | 0 | 0 | 67,749 | 172,759 |
| 2007-06 | 0 | 0 | 20,980 | 299,879 | 3,716 | 9,475 |
| 2007-04 | 0 | 0 | 0 | 0 | 43,931 | 112,023 |
| 2007-02 | 0 | 0 | 0 | 0 | 9,000 | 22,950 |
| 2007-01 | 0 | 0 | 0 | 0 | 327,591 | 835,354 |
| 2006-12 | 0 | 0 | 8,754 | 117,566 | 0 | 0 |
| 2006-11 | 15,200 | 182,400 | 5,328,212 | 63,938,544 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Innophos Holdings, Inc. (IPHS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-28 | Gonzalez De Salceda Jose Ramon (General Director) | Sale | 16,681 | 38.01 | 634,034 |
| 2008-08-27 | Golowski Joseph (Vice President-Sales) | Sale | 5,000 | 37.17 | 185,841 |
| 2008-08-19 | Bcip Trust Associates Iii-b (10% Owner) | Sale | 9,762 | 33.68 | 328,784 |
| 2008-08-18 | Bcip Trust Associates Iii-b (10% Owner) | Sale | 2,692 | 35.28 | 94,973 |
| 2008-08-18 | Bcip Associates Iii-b, Llc (10% Owner) | Sale | 2,692 | 35.28 | 94,973 |
| 2008-08-18 | Zide Stephen M (Director) | Sale | 5,636 | 35.28 | 198,838 |
| 2008-08-15 | Bcip Trust Associates Iii-b (10% Owner) | Sale | 7,069 | 35.10 | 248,121 |
| 2008-08-15 | Bcip Associates Iii-b, Llc (10% Owner) | Sale | 7,069 | 35.10 | 248,121 |
| 2008-08-15 | Zide Stephen M (Director) | Sale | 14,790 | 35.10 | 519,129 |
| 2008-08-12 | Treinen Tim (VP-Performance Chemicals) | Sale | 27,814 | 37.53 | 1,043,948 |
| 2008-08-12 | Treinen Tim (VP-Performance Chemicals) | Option Exercise | 23,934 | 2.55 | 61,031 |
| 2008-08-06 | Heyse Richard (VP-Chief Financial Officer) | Purchase | 15,000 | 35.18 | 527,662 |
| 2008-08-04 | Feuerbach Mark (VP-Treasury, FP&A) | Sale | 5,000 | 38.43 | 192,150 |
| 2008-08-01 | Thurston Mark (VP-Specialties) | Sale | 35,000 | 39.85 | 1,394,717 |
| 2008-07-23 | Thurston Mark (VP-Specialties) | Option Exercise | 33,138 | 2.55 | 84,501 |
| 2008-07-10 | Thurston Mark (VP-Specialties) | Sale | 20,000 | 29.05 | 581,086 |
| 2008-07-03 | Heyse Richard (VP-Chief Financial Officer) | Sale | 10,000 | 27.00 | 269,957 |
| 2008-07-01 | Feuerbach Mark (VP-Treasury, FP&A) | Option Exercise | 20,000 | 2.55 | 51,000 |
| 2008-07-01 | Farran William (VP & General Counsel) | Sale | 1,100 | 31.63 | 34,792 |
| 2008-07-01 | Harris Wilma (VP-Human Resources) | Option Exercise | 31,082 | 2.55 | 79,259 |
| 2008-07-01 | Thurston Mark (VP-Specialties) | Option Exercise | 20,000 | 2.55 | 51,000 |
| 2008-07-01 | Heyse Richard (VP-Chief Financial Officer) | Option Exercise | 6,800 | 2.55 | 17,340 |
| 2008-07-01 | Gress Randy (CEO) | Sale | 2,500 | 31.50 | 78,741 |
| 2008-06-17 | Thurston Mark (VP-Specialties) | Sale | 20,000 | 35.01 | 700,278 |
| 2008-06-10 | Bcip Trust Associates Iii-b (10% Owner) | Sale | 3,906,346 | 26.12 | 102,053,289 |
| 2008-06-10 | Bcip Associates Iii-b, Llc (10% Owner) | Sale | 600,000 | 26.12 | 15,675,000 |
| 2008-06-10 | Zide Stephen M (Director) | Sale | 3,906,346 | 26.12 | 102,053,289 |
| 2008-06-04 | Bcip Associates Iii-b, Llc (10% Owner) | Sale | 3,306,346 | 26.12 | 86,378,289 |
| 2008-05-05 | Feuerbach Mark (VP-Treasury, FP&A) | Sale | 5,000 | 17.80 | 89,023 |
| 2008-04-17 | Calvarin Louis (VP-Operations) | Sale | 4,700 | 17.13 | 80,511 |
| 2008-04-16 | Calvarin Louis (VP-Operations) | Sale | 5,300 | 17.09 | 90,577 |
| 2008-04-09 | Treinen Tim (VP-Performance Chemicals) | Sale | 14,700 | 16.59 | 243,853 |
| 2008-04-07 | Treinen Tim (VP-Performance Chemicals) | Sale | 2,373 | 16.52 | 39,198 |
| 2008-04-03 | Treinen Tim (VP-Performance Chemicals) | Sale | 4,773 | 16.51 | 78,801 |
| 2008-04-02 | Treinen Tim (VP-Performance Chemicals) | Sale | 436 | 16.52 | 7,202 |
| 2008-04-02 | Heyse Richard (VP & CFO) | Option Exercise | 6,800 | 2.55 | 17,340 |
| 2008-04-01 | Farran William (VP & General Counsel) | Sale | 1,100 | 16.40 | 18,040 |
| 2008-04-01 | Treinen Tim (VP-Performance Chemicals) | Sale | 130 | 16.50 | 2,145 |
| 2008-04-01 | Heyse Richard (VP & CFO) | Sale | 10,000 | 16.21 | 162,100 |
| 2008-04-01 | Gress Randy (CEO) | Sale | 2,500 | 16.35 | 40,875 |
| 2008-03-27 | Treinen Tim (VP-Performance Chemicals) | Sale | 23,600 | 16.05 | 378,780 |
| 2008-03-27 | Calvarin Louis (VP-Operations) | Sale | 600 | 16.00 | 9,600 |
| 2008-03-26 | Treinen Tim (VP-Performance Chemicals) | Sale | 6,400 | 16.01 | 102,464 |
| 2008-03-26 | Calvarin Louis (VP-Operations) | Sale | 4,400 | 16.02 | 70,470 |
| 2008-03-25 | Calvarin Louis (VP-Operations) | Sale | 10,000 | 15.52 | 155,240 |
| 2008-03-24 | Treinen Tim (VP-Performance Chemicals) | Sale | 13,000 | 15.15 | 196,925 |
| 2008-03-20 | Calvarin Louis (VP-Operations) | Sale | 4,800 | 14.59 | 70,018 |
| 2008-03-19 | Calvarin Louis (VP-Operations) | Sale | 5,200 | 14.70 | 76,416 |
| 2008-03-14 | Golowski Joseph (Vice President-Sales) | Sale | 4,500 | 13.66 | 61,455 |
| 2008-03-13 | Calvarin Louis (VP-Operations) | Sale | 8,481 | 14.00 | 118,770 |
| 2008-03-12 | Calvarin Louis (VP-Operations) | Sale | 4,519 | 14.02 | 63,359 |
| 2008-03-07 | Treinen Tim (VP-Performance Chemicals) | Sale | 8,754 | 13.75 | 120,399 |
| 2008-03-07 | Calvarin Louis (VP-Operations) | Sale | 2,000 | 14.03 | 28,064 |
| 2008-02-21 | Feuerbach Mark (VP-Treasury, FP&A) | Sale | 5,000 | 14.14 | 70,724 |
| 2008-01-04 | Heyse Richard (VP & CFO) | Sale | 4,300 | 13.57 | 58,346 |
| 2008-01-03 | Heyse Richard (VP & CFO) | Sale | 13,200 | 14.16 | 186,966 |
| 2008-01-03 | Heyse Richard (VP & CFO) | Option Exercise | 12,100 | 2.55 | 30,854 |
| 2008-01-02 | Farran William (VP & General Counsel) | Sale | 1,100 | 14.64 | 16,104 |
| 2008-01-02 | Heyse Richard (VP & CFO) | Sale | 12,500 | 14.48 | 181,052 |
| 2008-01-02 | Gress Randy (CEO) | Sale | 2,500 | 14.49 | 36,216 |
| 2007-12-21 | Heyse Richard (VP & CFO) | Sale | 7,800 | 14.56 | 113,551 |
| 2007-12-20 | Heyse Richard (VP & CFO) | Sale | 10,700 | 14.52 | 155,404 |
| 2007-12-19 | Heyse Richard (VP & CFO) | Sale | 11,500 | 14.50 | 166,722 |
| 2007-11-16 | Heyse Richard (VP & CFO) | Sale | 10,000 | 13.00 | 129,975 |
| 2007-10-22 | Feuerbach Mark (VP-Tres, Fin Plning & Analysis) | Sale | 20,000 | 15.07 | 301,482 |
| 2007-10-05 | Feuerbach Mark (VP-Tres, Fin Plning & Analysis) | Option Exercise | 20,000 | 2.55 | 51,000 |
| 2007-10-01 | Farran William (VP & General Counsel) | Sale | 4,100 | 15.14 | 62,061 |
| 2007-10-01 | Heyse Richard (VP & CFO) | Sale | 1,472 | 15.14 | 22,281 |
| 2007-10-01 | Heyse Richard (VP & CFO) | Option Exercise | 1,472 | 2.55 | 3,753 |
| 2007-10-01 | Gress Randy (CEO) | Sale | 9,000 | 15.14 | 136,233 |
| 2007-07-12 | Gress Randy (CEO) | Option Exercise | 60,599 | 2.55 | 154,527 |
| 2007-07-02 | Heyse Richard (VP & CFO) | Option Exercise | 7,150 | 2.55 | 18,232 |
| 2007-06-08 | Thurston Mark (VP-Specialty Salts) | Sale | 10,000 | 13.89 | 138,851 |
| 2007-06-05 | Feuerbach Mark (VP-Tres, Fin Plning & Analysis) | Sale | 6,080 | 14.52 | 88,273 |
| 2007-06-04 | Farran William (VP & General Counsel) | Sale | 4,900 | 14.85 | 72,755 |
| 2007-06-01 | Feuerbach Mark (VP-Tres, Fin Plning & Analysis) | Option Exercise | 3,716 | 2.55 | 9,475 |
| 2007-04-04 | Thurston Mark (VP-Specialty Salts) | Option Exercise | 30,000 | 2.55 | 76,500 |
| 2007-04-02 | Treinen Tim (VP-Performance Chemicals) | Option Exercise | 4,788 | 2.55 | 12,209 |
| 2007-04-02 | Heyse Richard (VP & CFO) | Option Exercise | 6,750 | 2.55 | 17,212 |
| 2007-04-02 | Godber John (VP - Research & Develpoment) | Option Exercise | 2,393 | 2.55 | 6,102 |
| 2007-02-02 | Heyse Richard (VP & CFO) | Option Exercise | 9,000 | 2.55 | 22,950 |
| 2007-01-29 | Feuerbach Mark (VP-Tres, Fin Plning & Analysis) | Option Exercise | 40,000 | 2.55 | 102,000 |
| 2007-01-19 | Godber John (VP - Research & Develpoment) | Option Exercise | 28,721 | 2.55 | 73,238 |
| 2007-01-11 | Calvarin Louis (Vice President-Operations) | Option Exercise | 40,000 | 2.55 | 102,000 |
| 2007-01-10 | Harris Wilma (VP - Human Resources) | Option Exercise | 12,000 | 2.55 | 30,599 |
| 2007-01-02 | Treinen Tim (VP-Performance Chemicals) | Option Exercise | 57,442 | 2.55 | 146,477 |
| 2007-01-02 | Heyse Richard (VP & CFO) | Option Exercise | 71,985 | 2.55 | 183,561 |
| 2007-01-02 | Haaijer Eric (VP - Commercial Operations) | Option Exercise | 57,443 | 2.55 | 146,479 |
| 2006-12-04 | Godber John (VP - Research & Development) | Sale | 8,754 | 13.43 | 117,566 |
| 2006-11-09 | Bcip Trust Associates Iii-b (10% Owner) | Sale | 1,304,348 | 12.00 | 15,652,176 |
| 2006-11-09 | Bcip T Associates Iii, Llc (10% Owner) | Sale | 1,304,348 | 12.00 | 15,652,176 |
| 2006-11-09 | Hendrix Blair E (Director) | Sale | 110,820 | 12.00 | 1,329,840 |
| 2006-11-09 | Zide Stephen M (Director) | Sale | 1,304,348 | 12.00 | 15,652,176 |
| 2006-11-09 | Conard Edward (Director) | Sale | 1,304,348 | 12.00 | 15,652,176 |
| 2006-11-07 | Thurston Mark (Vice President-Specialities) | Purchase | 200 | 12.00 | 2,400 |
| 2006-11-07 | Heyse Richard (VP & CFO) | Purchase | 13,000 | 12.00 | 156,000 |
| 2006-11-07 | Haaijer Eric (VP - Commercial Operations) | Purchase | 2,000 | 12.00 | 24,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Innophos Holdings, Inc. (symbol IPHS,
CIK number 1364099) see
the Securities and Exchange Commission (SEC) website.
|
|
